Nektar Therapeutics
NKTR· Nasdaq
Released Feb 28, 2019, after the close
10-K filed Mar 1, 2019, 60 days after period end · 0001564590-19-005639
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $39.83M | $95.47M | $37.45M | $39.37M |
| Net Income | -$98.21M | -$33.83M | -$42.20M | -$54.14M |
| EPS Diluted |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.57 |
| -$0.21 |
| -$0.28 |
| -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.